Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury

Journal of Neurochemistry

Volumn 73, Issue 6, 1999, Pages 2586-2599

  Kholodilov, Nikolai G ^a   Neystat, Michael ^a   Oo, Tinmarla F ^a   Lo, Steven E ^a   Larsen, Kristin E ^a   Sulzer, David ^a   Burke, Robert E ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Apoptosis; Dopaminergic neurons; Parkinson's disease; Programmed cell death; Substantia nigra; Synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; DOPAMINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES; IN SITU HYBRIDIZATION; MOLECULAR SEQUENCE DATA; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; NEUROTOXINS; PARKINSON DISEASE; QUINOLINIC ACID; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, ANTISENSE; RNA, MESSENGER; SUBSTANTIA NIGRA; SUBTRACTION TECHNIQUE; SYNUCLEINS;

ANIMALIA; RODENTIA;

EID: 0032707654     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0732586.x     Document Type: Article

References (59)

1. Altschul S. F., Gish W., Miller W., Myers E. W., and Lipman D. J. (1990) Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
2. Arawaka S., Saito Y., Murayama S., and Mori H. (1998) Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Neurology 51, 887-889.
3. Burke R. E., Macaya A., DeVivo D., Kenyon N., and Janec E. M. (1992) Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons. Neuroscience 50, 559-569.
4. Burke R. E., Franklin S. O., and Inturrisi C. E. (1994) Acute and persistent suppression of preproenkephalin mRNA expression in the striatum following developmental hypoxic-ischemic injury. J. Neurochem. 62, 1878-1886.
5. Burke R. E., Antonelli M., and Sulzer D. (1998) Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J. Neurochem. 71, 517-525.
6. Clarke P. G. H. (1985) Neuronal death in the development of the vertebrate nervous system. Trends Neurosci. 8, 345-349.
7. Clayton D. F. and George J. M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21, 249-254.
8. Colley W. C., Sung T. C., Roll R., Jenco J., Hammond S. M., Altshuller Y., Bar-Sagi D., Morris A. J., and Frohman M. A. (1997) Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7, 191-201.
9. Coyle J. T. (1977) Biochemical aspects of neurotransmission in the developing brain. Int. Rev. Neurobiol. 20, 65-102.
10. El-Agnaf O. M., Jakes R., Curran M. D., Middleton D., Ingenito R., Bianchi E., Pessi A., Neill D., and Wallace A. (1998) Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett. 440, 71-75.
11. Estus S., Zaks W. J., Freeman R. S., Gruda M., Bravo R., and Johnson E. M. (1994) Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127, 1717-1727.
12. Fesus L., Davies P. J. A., and Piacentini M. (1991) Apoptosis: molecular mechanisms in programmed cell death. Eur. J. Cell Biol. 56, 170-177.
13. George J. M., Jin H., Woods W. S., and Clayton D. F. (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15, 361-372.
14. Han H., Weinreb P. H., and Lansbury P. T. J. (1995) The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 2, 163-169.
15. Hashimoto M., Hsu L. J., Sisk A., Xia Y., Takeda A., Sundsmo M., and Masliah E. (1998) Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res. 799, 301-306.
16. Irizarry M. C., Kim T. W., McNamara M., Tanzi R. E., George J. M., Clayton D. F., and Hyman B. T. (1996) Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J. Neuropathol. Exp. Neurol. 55, 889-895.
17. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H. A. R., Kittel A., and Saitoh T. (1995a) The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467-475.
18. Iwai A., Yoshimoto M., Masliah E., and Saitoh T. (1995b) Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 34, 10139-10145.
19. Jakes R., Spillantini M. G., and Goedert M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27-32.
20. Janec E. and Burke R. E. (1993) Naturally occurring cell death during postnatal development of the substantia nigra of the rat. Mol. Cell. Neurosci. 4, 30-35.
21. Jenco J. M., Rawlingson A., Daniels B., and Morris A. J. (1998) Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. Biochemistry 37, 4901-4909.
22. Jensen P. H., Sorensen E. S., Petersen T. E., Gliemann J., and Rasmussen L. K. (1995) Residues in the synuclein consensus motif of the α-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid βA4 peptide. Biochem. J. 310, 91-94.
23. Jeon B. S., Kholodilov N. G., Oo T. F., Kim S.-Y., Tomaselli K. J., Srinivasan A., Stefanis L., and Burke R. E. (1999) Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J. Neurochem. 73, 322-333.
24. Ji H., Liu Y. E., Jia T., Wang M., Liu J., Xiao G., Joseph B. K., Rosen C., and Shi Y. E. (1997) Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res. 57, 759-764.
25. Kelly W. J. and Burke R. E. (1996) Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent. Neurosci. Lett. 220, 85-88.
26. Kholodilov N. G., Neystat M., and Burke R. E. (1997) Investigation of apoptotic neuron death in substantia nigra with mRNA differential display. (Abstr.) Neurology 48, A322.
27. Kholodilov N. G., Oo T. F., and Burke R. E. (1999) Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine. Neurosci. Lett. (in press).
28. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L., and Riess O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
29. Lavedan C. (1998) The synuclein family. Genome Res. 8, 871-880.
30. Lavedan C., Leroy E., Dehejia A., Buchholtz S., Dutra A., Nussbaum R. L., and Polymeropoulos M. H. (1998) Identification, localization and characterization of the human gamma-synuclein gene. Hum. Genet. 103, 106-112.
31. Macaya A., Munell F., Gubits R. M., and Burke R. E. (1994) Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc. Natl. Acad. Sci. USA 91, 8117-8121.
32. Mackay D. J. G., Nobes C. D., and Hall A. (1995) The Rho's progress: a potential role during neuritogenesis for the Rho family of GT-Pases. Trends Neurosci. 18, 496-501.
33. Maroteaux L. and Scheller R. H. (1991) The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Mol. Brain Res. 11, 335-343.
34. Maroteaux L., Campanelli J. T., and Scheller R. H. (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
35. Marti M. J., James C. J., Oo T. F., Kelly W. J., and Burke R. E. (1997) Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J. Neurosci. 17, 2030-2039.
36. Mena M. A., Davila V., and Sulzer D. (1997) Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures. J. Neurochem. 69, 1398-1408.
37. Mochizuki H., Goto K., Mori H., and Mizuno Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137, 120-123.
38. Morgan J. I. and Curran T. (1995) The immediate-early gene response and neuronal death and regeneration. Neuroscientist 1, 68-75.
39. Nakajo S., Tsukada K., Omata K., Nakamura Y., and Nakaya K. (1993) A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. Eur. J. Biochem. 217, 1057-1063.
40. Nakajo S., Shioda S., Nakai Y., and Nakaya K. (1994) Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization. Mol. Brain Res. 27, 81-86.
41. Neystat M., Lynch T., Przedborski S., Kholodilov N. G., Rzhetskaya M., and Burke R. E. (1999) Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease. Mov. Disord. 14, 417-422.
42. Oo T. F. and Burke R. E. (1997) The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev. Brain Res. 98, 191-196.
43. Oo T. F., Henchcliffe C., James D., and Burke R. E. (1999) Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra. J. Neurochem. 72, 557-564.
44. Ostrerova N., Petrucelli L., Farrer M., Mehta N., Choi P., Hardy J., and Wolozin B. (1999) Alpha-synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 19, 5782-5791.
45. Paxinos G. and Walson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
46. Perry M. J. M. and Haynes L. W. (1993) Localization and activity of transglutaminase, a retinoid-inducible protein, in developing rat spinal cord. Int. J. Dev. Neurosci. 11, 325-337.
47. Petersen K., Diesen O. F., and Mikkelsen J. D. (1999) Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex. Neuroscience 91, 651-659.
48. Phillips J. and Eberwine J. H. (1996) Antisense RNA amplification: a linear amplification method for analyzing the mRNA population from single living cells. Methods 10, 283-288.
49. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Golbe L. I., and Nussbaum R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
50. Pothos E. N., Davila V., and Sulzer D. (1998) Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J. Neurosci. 18, 4106-4118.
51. Przedborski S., Khan U., Kostic V., Carlson E., Epstein C. J., and Sulzer D. (1996) Increased superoxide dismutase activity improves survival of cultured postnatal midbrain neurons. J. Neurochem. 67, 1383-1392.
52. Rayport S., Sulzer D., Shi W. X., Sawasdikosol S., Monaco J., Batson D., and Rajendran G. (1992) Identified postnatal mesolimbic dopamine neurons in culture: morphology and electrophysiology. J. Neurosci. 12, 4264-4280.
53. Spillantini M. G., Schmidt M. L., Lee V. M. Y., Trojanowski J. Q., Jakes R., and Goedert M. (1997) α-Synuclein in Lewy bodies. Nature 388, 839-840.
54. Sulzer D., Maidment N. T., and Rayport S. (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527-535.
55. Surguchov A., Surgucheva I., Solessio E., and Baehr W. (1999) Synoretin - a new protein belonging to the synuclein family. Mol. Cell. Neurosci. 13, 95-103.
56. Tompkins M. M., Basgall E. J., Zamrini E., and Hill W. D. (1997) Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 150, 119-131.
57. Tu P. H., Galvin J. E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J. Q., and Lee V. M. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol. 44, 415-422.
58. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D. A. C., Kondo J., Ihara Y., and Saitoh T. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 11282-11286.
59. Withers G. S., George J. M., Banker G. A., and Clayton D. F. (1997) Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. Dev. Brain Res. 99, 87-94.